Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection.

< BACK TO ARCHIVE


2021 May 31


Tumori


http://www.ncbi.nlm.nih.gov/pubmed/34057376?dopt=Abstract

Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection.

Authors

Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection.
Rosboch G L, Ceraolo E, De Domenici I, Guerrera F, Balzani E, Lyberis P, Ruffini E, Brazzi L
Tumori. 2021 May 31:3008916211020093.
PMID: 34057376.

Abstract

The choice of analgesia after cancer surgery may play a role in the onset of cancer recurrence. Particularly opioids seem to promote cancer cell proliferation and migration. Based on this consideration, we assessed the impact of perioperative analgesia choice on cancer recurrence after curative surgery for stage I non-small cell lung cancer (NSCLC).
Read This Paper